Colorectal Cancer Therapeutics Market

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

Colorectal Cancer Therapeutics Market contains market size and forecasts of Colorectal Cancer Therapeutics in Global, including the following market information:

• Global Colorectal Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Colorectal Cancer Therapeutics market was valued at 12490 million in 2021 and is projected to reach US$ 17250 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Colorectal Cancer Therapeutics include Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Colorectal Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Colorectal Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Colorectal Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Diagnostics
• Therapeutics

Global Colorectal Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Colorectal Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinic
• Research Institutions

Global Colorectal Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Colorectal Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Colorectal Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Colorectal Cancer Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Taiho Pharma
• Merck KGaA
• Amgen
• Takeda
• Roche
• Eli Lilly
• Sanofi
• Regeneron
• Bayer
• Onyx
• Bristol-Myers Squib
• Sumitomo Dainippon Pharma
• Array BioPharma
• Hutchison MediPharma
• Jiangsu Hengrui Medicine
• Jiangsu Chia-Tai Tianqing
• Suzhou Zelgen Biopharmaceuticals